GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Thyrocare Technologies Ltd

Thyrocare Technologies Q2 FY27 Standalone PAT at Rs. 48.13 Crores

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 29 Oct 2026, 03:59 PM IST  ·  BSE ID: f2e61a0b-9f59-48b6-9656-69d89e925166
View Original BSE Filing (PDF)
💡
In Simple Terms
Thyrocare Technologies reported its quarterly and half-yearly financial results, with Rs. 256.25 Crores in revenue for the quarter.
🤖 AI Summary
  • Thyrocare Technologies' Board approved Q2 FY27 Unaudited Standalone and Consolidated Financial Results.
  • Standalone Revenue from Operations for Q2 FY27 was Rs. 256.25 Crores.
  • Standalone Profit After Tax for the quarter ended September 30, 2026, totaled Rs. 48.13 Crores.
  • Half-year Standalone Revenue from Operations (H1 FY27) reached Rs. 481.91 Crores.
  • Half-year Standalone Profit After Tax (H1 FY27) stood at Rs. 98.30 Crores.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operations (Q2 FY27)
Rs. 256.25 Crores
26.71%
Standalone Profit for the Period (Q2 FY27)
Rs. 48.13 Crores
11.85%
Standalone Revenue from Operations (H1 FY27)
Rs. 481.91 Crores
26.43%
Standalone Profit for the Period (H1 FY27)
Rs. 98.30 Crores
24.30%
Basic EPS (Q2 FY27)
Rs. 3.03
12.22%
🏢 How This Affects the Company
📈
Business Impact
The company's core diagnostic services generated Rs. 256.25 Crores in standalone revenue from operations for the quarter, indicating continued business activity. Half-year revenue from operations was Rs. 481.91 Crores.
💰
Financial Impact
Standalone profit for the quarter was Rs. 48.13 Crores, contributing to a half-year profit of Rs. 98.30 Crores. Total equity stood at Rs. 558.30 Crores as of September 30, 2026.
⚙️
Operational Impact
Employee benefits expense increased to Rs. 43.24 Crores for the quarter from Rs. 31.37 Crores in the prior year quarter, indicating potential changes in workforce costs. Other expenses also saw an increase to Rs. 59.20 Crores from Rs. 44.58 Crores YoY.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the reported standalone Q2 FY27 revenue of Rs. 256.25 Crores and PAT of Rs. 48.13 Crores.
🔍
Management Signal
The Board's approval and disclosure of these results signal adherence to regulatory compliance and transparent reporting of financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — check revenue and profit growth trends.
Investor presentation and earnings call details for further management commentary.
Updates on changes in cash and bank balances in subsequent filings.
LOW RISK The filing reports routine financial results with no specific new risks identified.
💡 Investor Takeaway
Thyrocare Technologies reported Q2 FY27 standalone revenue from operations of Rs. 256.25 Crores, a 26.71% increase from Rs. 202.23 Crores YoY. Standalone Profit After Tax reached Rs. 48.13 Crores, growing 11.85% from Rs. 43.03 Crores YoY.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone Revenue from Operations for Q2 FY27 increased to Rs. 256.25 Crores from Rs. 202.23 Crores in Q2 FY26, representing 26.71% YoY growth.
  • Standalone Profit for the period for Q2 FY27 grew to Rs. 48.13 Crores from Rs. 43.03 Crores in Q2 FY26, a 11.85% YoY increase.

⚠️ Concerns

  • Exceptional Items for the quarter ended September 30, 2026, recorded a negative impact of Rs. 9.17 Crores.
  • Cash and cash equivalents decreased to Rs. 16.98 Crores as of September 30, 2026, from Rs. 32.88 Crores as of March 31, 2026.
📅 Company Track Record
Thyrocare Technologies' Q1 FY27 consolidated PAT surged 34.1% YoY to INR 51.33 crore, and Q1 FY27 revenue was up 24% to INR 240.02 Cr, as reported in filings dated July 23, 2026. This shows a continued trend of revenue and profit growth in FY27.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Thyrocare Technologies' standalone revenue from operations for Q2 FY27?
Thyrocare Technologies reported a standalone revenue from operations of Rs. 256.25 Crores for the quarter ended September 30, 2026.
What was Thyrocare Technologies' standalone net profit for Q2 FY27?
The standalone Profit for the period (PAT) for Thyrocare Technologies in Q2 FY27 was Rs. 48.13 Crores.
How did Thyrocare Technologies' half-year standalone revenue perform for H1 FY27?
Thyrocare Technologies' standalone revenue from operations for the six months ended September 30, 2026, was Rs. 481.91 Crores.
What was the Basic EPS for Thyrocare Technologies in Q2 FY27?
The Basic Earnings per Share (EPS) for Thyrocare Technologies for Q2 FY27 was Rs. 3.03.
Were there any exceptional items in Thyrocare Technologies' Q2 FY27 standalone results?
Yes, Thyrocare Technologies recorded Exceptional Items of (Rs. 9.17) Crores for the quarter ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.